![Johanna Friedl-Naderer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Johanna Friedl-Naderer
Corporate Officer/Principal chez
DYNE THERAPEUTICS, INC.
Fortune : 4 M $ au 31/08/2026
Profil
Johanna Friedl-Naderer is currently the Director at Biogen Idec Ltd. and the Chief Commercial Officer at Dyne Therapeutics, Inc. She previously held positions as Director at the International Federation of Pharmaceutical Manufacturers, the Swiss-American Chamber of Commerce, the European Federation of Pharmaceutical Industries & Assns, and Interpharma.
From 2001 to 2022, she served as the President-Europe, Canada & Partner Markets at Biogen, Inc. She also worked as the Chief Operating Officer & Executive Vice President at Vir Biotechnology, Inc. from 2022 to 2023.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/09/2026 | 152 897 ( 0,08% ) | 4 M $ | 31/08/2026 |
Postes actifs de Johanna Friedl-Naderer
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 03/09/2024 |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Directeur/Membre du Conseil | 04/12/2014 |
Anciens postes connus de Johanna Friedl-Naderer
| Sociétés | Poste | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Directeur des opérations | 29/09/2023 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2022 |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology Provides biopharmaceutical research services | Directeur/Membre du Conseil | - |
Interpharma
 Interpharma Miscellaneous Commercial ServicesCommercial Services Operates as an association of research-based pharmaceutical companies | Directeur/Membre du Conseil | - |
Swiss-American Chamber of Commerce
 Swiss-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Swiss-American Chamber of Commerce
Swiss-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Health Technology |
Interpharma
Interpharma Miscellaneous Commercial ServicesCommercial Services Operates as an association of research-based pharmaceutical companies | Commercial Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
